アロステル活性化剤によるSIRT1調節の一般的なメカニズムの証拠
Basil P Hubbard1, Ana P Gomes, Han Dai
1Department of Genetics, Harvard Medical School, Boston, MA 02115, USA.
まとめ
サーチューイン活性化化合物 (STAC) は,その基板の水嫌性モチーフと相互作用することによってSIRT1を活性化します. SIRT1内の特定のグルタミン酸残留は,この活性化に不可欠であり,多様なSTACsの共通のアロステリックメカニズムを明らかにします.
科学分野:
- バイオケミストリー バイオケミストリー
- 分子生物学は分子生物学である.
- 老化に関する研究
背景:
- SIRT1デセチラゼは,年齢関連の疾患の治療における重要な標的である.
- シルトゥイン活性化化合物 (STACs) の正確なメカニズムについては,まだ議論が続いている.
- STACのメカニズムを理解することは,効果的な治療法の開発に不可欠です.
研究 の 目的:
- STACsがSIRT1.1を活性化する分子メカニズムを解明する.
- STAC媒介による活性化に関与するSIRT1とその基板の重要な構造的特徴を特定する.
- 化学的に多様なSTACsに共通の活性化メカニズムが存在するかどうかを判断する.
主な方法:
- STAC結合におけるSIRT1基板 (例えば,PGC-1α,FOXO3a) の水害性モチーフの役割を調査した.
- サイト指向型変異を生成して,SIRT1の特定のアミノ酸の機能,特にGlu230の機能を調べました.
- 野生型のSIRT1変異体と活性化欠陥SIRT1変異体を発現する原始細胞におけるSTACの代謝効果を評価した.
主要な成果:
- SIRT1基板内の特定の水性モチーフは,STAC誘発活性化に不可欠である.
- SIRT1のN末端領域にある単一のアミノ酸であるGlu(230) は,テストされたすべてのSTACスキャフォルドによる活性化に不可欠です.
- STACは,活性化欠陥SIRT1変異体を発現する細胞に代謝効果を誘発できず,SIRT1の直接的関与を確認しました.
結論:
- SIRT1は,保存されたアロステリックメカニズムを通じて,STACによって直接活性化することができます.
- これらの発見は,STACの有効性にとって,基板と相互作用する領域およびGlu ((230) のような特定の残留物の重要性を強調しています.
- この研究は,年齢に関連する疾患に対する新しいSIRT1標的薬の開発のためのメカニズム的基礎を提供します.
関連する概念動画
Allosteric Regulation
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
Allosteric Regulation
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
Allosteric Proteins-ATCase
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Ligand Binding and Linkage
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
Regulation of Metabolism
Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
